Investor List:

Top Pharmaceuticals Series A Investors in Seattle / Portland (25)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Pharmaceuticals investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Ling Wong, Managing Partner at Highbury Group
Ling Wong
Highbury Group·Managing Partner
Sweet spot: $10.0M
Range: $500K - $50.0M
Investors in San Francisco (CA), Investors in Seattle (WA)
Investors in Consumer Health (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Consumer Health (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in ClimateTech/CleanTech (Seed), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in Pharmaceuticals (Series B), Investors in Seattle / Portland (Other Lists), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series B), Investors in BioTech (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in Consumer Health (Seed), Investors in Consumer Health (Seed), Investors in BioTech (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Seed), Investors in Health & Hospital Services (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Seed), Investors in ClimateTech/CleanTech (Series A), Investors in Consumer Health (Series A), Investors in BioTech (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in Consumer Health (Series A), Investors in Health IT (Series A), Investors in Health IT (Series A), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series A), Investors in Consumer Health (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in Health IT (Series B), Investors in Pharmaceuticals (Series B), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Pharmaceuticals (Series B), Investors in Health & Hospital Services (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Digital Health (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in Diagnostics (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Generative Tech/AI (Series B), Investors in Generative Tech/AI (Seed), Investors in Generative Tech/AI (Seed), Investors in Generative Tech/AI (Series B), Investors in Generative Tech/AI (Series A), Investors in Generative Tech/AI (Series B), Investors in Generative Tech/AI (Series A), Investors in Generative Tech/AI (Seed), Investors in Generative Tech/AI (Series A), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in AI (Series B), Investors in Investors who were founders (Other Lists), Investors in AI (Seed), Investors in AI (Seed), Investors in AI (Seed), Investors in AI (Series A), Investors in AI (Series A), Investors in AI (Series B), Investors in AI (Series B), Investors in AI (Series A)
Photo of Steven Gillis, Managing Director at ARCH Venture Partners
Steven Gillis
ARCH Venture Partners·Managing Director
Sweet spot: $25.0M
Range: $50K - $150.0M
Investors in Seattle (WA)
Photo of Leen Kawas, General Partner at Propel Bio Partners
Leen Kawas
Propel Bio Partners·General Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Seattle (WA)
Photo of Lisa Stone, Managing Director at WestRiver Group
Lisa Stone
WestRiver Group·Managing Director
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Seattle (WA)
Photo of Linda Li, Venture Partner at Remiges Ventures
Linda Li
Remiges Ventures·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Seattle (WA), Investors in Boston (MA), Investors in Japan
Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in Consumer Health (Series A), Investors in Pharmaceuticals (Series B), Investors in Seattle / Portland (Other Lists), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series B), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in Consumer Health (Series A), Investors in Health IT (Series A), Investors in Health IT (Series A), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series A), Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in Consumer Health (Series B), Investors in Health IT (Series B), Investors in Health IT (Series B), Investors in Pharmaceuticals (Series B), Investors in Health & Hospital Services (Series B), Investors in Pharmaceuticals (Series B), Investors in Health & Hospital Services (Series B), Investors in Boston / New England (Other Lists), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in Digital Health (Series A)
Photo of Matthew Wahlrab, Venture Partner at Boutique Venture Partners
Matthew Wahlrab
Boutique Venture Partners·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Bellevue (WA)
Photo of Luciana Borio, Venture Partner at ARCH Venture Partners
Luciana Borio
ARCH Venture Partners·Venture Partner
Sweet spot: $25.0M
Range: $50K - $150.0M
Investors in Seattle (WA), Investors in Dublin (Ireland), Investors in SF Bay Area (CA), Investors in Chicago (IL)
Investors in Medical Devices (Seed), Investors in Consumer Health (Series B), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Consumer Health (Series A), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Seattle / Portland (Other Lists), Investors in Consumer Health (Seed), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series B), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in Consumer Health (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Medical Devices (Seed), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Series A), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in San Francisco Bay Area (Other Lists), Investors in BioTech (Series A), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in Consumer Health (Series A), Investors in Consumer Health (Series A), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in Health IT (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Medical Devices (Series A), Investors in Health IT (Series A), Investors in BioTech (Series B), Investors in Medical Devices (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series B), Investors in Consumer Health (Series B), Investors in Consumer Health (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Health & Hospital Services (Series B), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series B), Investors in Washington, D.C. (Other Lists), Investors in Midwest (Other Lists), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Digital Health (Series B), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Consumer Health (Seed), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Photo of Jonathan Lim, Venture Partner at ARCH Venture Partners
Jonathan Lim
ARCH Venture Partners·Venture Partner
Sweet spot: $25.0M
Range: $50K - $50.0M
Investors in Dublin (Ireland), Investors in San Francisco (CA), Investors in Seattle (WA), Investors in Chicago (IL)
Investors in Medical Devices (Seed), Investors in Consumer Health (Series B), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Consumer Health (Series A), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Seattle / Portland (Other Lists), Investors in Consumer Health (Seed), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series B), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in Los Angeles / Southern California (Other Lists), Investors in Consumer Health (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Medical Devices (Seed), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Series A), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in Consumer Health (Series A), Investors in Consumer Health (Series A), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in Health IT (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Medical Devices (Series A), Investors in Health IT (Series A), Investors in BioTech (Series B), Investors in Medical Devices (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series B), Investors in Consumer Health (Series B), Investors in Consumer Health (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Health & Hospital Services (Series B), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series B), Investors in Midwest (Other Lists), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Digital Health (Series B), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Consumer Health (Seed), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Get new data & insights delivered to your inbox